DK288287D0 - Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande - Google Patents

Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande

Info

Publication number
DK288287D0
DK288287D0 DK288287A DK288287A DK288287D0 DK 288287 D0 DK288287 D0 DK 288287D0 DK 288287 A DK288287 A DK 288287A DK 288287 A DK288287 A DK 288287A DK 288287 D0 DK288287 D0 DK 288287D0
Authority
DK
Denmark
Prior art keywords
allergic
treatment
pharmaceutical preparations
heterocyclic compounds
inflammatory conditions
Prior art date
Application number
DK288287A
Other languages
English (en)
Other versions
DK288287A (da
Inventor
Yoshihiko Kitaura
Fumitaka Ito
Rodney William Stevens
Nobuko Asai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK288287D0 publication Critical patent/DK288287D0/da
Publication of DK288287A publication Critical patent/DK288287A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fats And Perfumes (AREA)
  • External Artificial Organs (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Hydrogenated Pyridines (AREA)
DK288287A 1986-06-09 1987-06-04 Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande DK288287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13347086 1986-06-09

Publications (2)

Publication Number Publication Date
DK288287D0 true DK288287D0 (da) 1987-06-04
DK288287A DK288287A (da) 1987-12-10

Family

ID=15105525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK288287A DK288287A (da) 1986-06-09 1987-06-04 Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande

Country Status (21)

Country Link
EP (1) EP0249407B1 (da)
JP (1) JPH0623199B2 (da)
KR (1) KR900000552B1 (da)
CN (1) CN1015334B (da)
AT (1) ATE60596T1 (da)
AU (1) AU586337B2 (da)
CA (1) CA1305151C (da)
DD (1) DD265141A5 (da)
DE (1) DE3767778D1 (da)
DK (1) DK288287A (da)
ES (1) ES2031892T3 (da)
FI (1) FI87924C (da)
GR (1) GR3001584T3 (da)
HU (1) HU198451B (da)
IE (1) IE60015B1 (da)
NO (1) NO168246C (da)
PL (1) PL150631B1 (da)
PT (1) PT85035B (da)
SU (1) SU1757464A3 (da)
YU (1) YU45423B (da)
ZA (1) ZA874046B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720297A (en) * 1985-09-27 1988-01-19 Sumitomo Chemical Company, Limited Benzothiazolones, and their production and use as herbicides
JPH0283376A (ja) * 1988-09-19 1990-03-23 Pfizer Pharmaceut Co Ltd ベンゾオキサゾロン誘導体および抗アレルギー又は抗炎症組成物
IL93473A0 (en) * 1989-02-28 1990-11-29 Pfizer Antiinflammatory benzoxazolones
JPH0678327B2 (ja) * 1989-07-20 1994-10-05 ファイザー製薬株式会社 4,5,6,7,―四置換ベンゾオキサゾロン類
JPH0729998B2 (ja) * 1990-01-22 1995-04-05 ファイザー製薬株式会社 新規ベンゾキノン化合物およびその組成物
US5972980A (en) * 1995-10-05 1999-10-26 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
AU6966696A (en) * 1995-10-05 1997-04-28 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
JP2004529110A (ja) 2001-03-06 2004-09-24 アストラゼネカ アクチボラグ 脈管損傷活性を有するインドール誘導体
DE10210779A1 (de) 2002-03-12 2003-10-09 Merck Patent Gmbh Cyclische Amide
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
US7270805B1 (en) * 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists
JP5964965B2 (ja) * 2011-08-18 2016-08-03 ドクター レディズ ラボラトリーズ リミテッド コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物
JP6125619B2 (ja) * 2012-05-21 2017-05-10 ドクトア・アウグスト・ボルフ・ゲーエムベーハー・ウント・コンパニー・カー・ゲー−アルツナイミツテル 新規な1,3−ベンゾオキサゾール−2(3h)−オンならびに医薬品および化粧品としてのこれらの使用
EP3932395A1 (en) * 2020-07-03 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Stable emulsion containing an active pharmaceutical ingredient based on n(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)dodecanamide, production and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663972A (en) * 1979-10-30 1981-05-30 Tetsujirou Masuko Preparation of novel benzothiazolone derivative containing novel heterocyclic quaternary salt
DE3017977A1 (de) * 1980-05-10 1981-11-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte 2(3h)-benzothiazolone
DE3042481A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
GB8325370D0 (en) * 1983-09-22 1983-10-26 Fujisawa Pharmaceutical Co Benzoxazoline and benzothiazoline derivatives
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
DE3767778D1 (de) 1991-03-07
IE60015B1 (en) 1994-05-18
HU198451B (en) 1989-10-30
DK288287A (da) 1987-12-10
GR3001584T3 (en) 1992-11-23
EP0249407B1 (en) 1991-01-30
NO872382D0 (no) 1987-06-05
ZA874046B (en) 1989-01-25
PL266132A1 (en) 1988-06-23
JPH0623199B2 (ja) 1994-03-30
NO872382L (no) 1987-12-10
EP0249407A3 (en) 1988-10-19
FI872555A (fi) 1987-12-10
JPS63107958A (ja) 1988-05-12
CN1015334B (zh) 1992-01-29
DD265141A5 (de) 1989-02-22
ATE60596T1 (de) 1991-02-15
YU45423B (en) 1992-05-28
PT85035A (en) 1987-07-01
FI87924B (fi) 1992-11-30
HUT48209A (en) 1989-05-29
NO168246B (no) 1991-10-21
CA1305151C (en) 1992-07-14
IE871505L (en) 1987-12-09
SU1757464A3 (ru) 1992-08-23
PT85035B (pt) 1990-03-08
FI87924C (fi) 1993-03-10
CN87104099A (zh) 1988-02-10
EP0249407A2 (en) 1987-12-16
NO168246C (no) 1992-01-29
KR900000552B1 (ko) 1990-01-31
YU104987A (en) 1988-08-31
KR880000413A (ko) 1988-03-25
ES2031892T3 (es) 1996-07-16
PL150631B1 (en) 1990-06-30
AU7387887A (en) 1987-12-10
AU586337B2 (en) 1989-07-06
FI872555A0 (fi) 1987-06-08

Similar Documents

Publication Publication Date Title
DK288287D0 (da) Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
DK0428312T3 (da) Hypoglykæmiske oxazolidindionderivater
FI911443A (fi) Foerfarande foer framstaellning av 3,5-di-tert.butyl-4-hydroxifenylmetylenderivat av 2-substituerade tiazolidinoner, oxazolidinoner och imidazolidinoner med antiinflammatorisk aktivitet.
ES8401019A1 (es) "un compuesto".
DE3786365D1 (de) 5h-1,3,4-thiadiazolo(3,2-a)pyrimidin-5-on-derivate und diese enthaltende gartenbau- und landwirtschaftliche fungizidmittel.
ATE107636T1 (de) Substituierte phenyl-2-propensäure derivate und ihre verwendung als fungizide.
DE3772015D1 (de) Chinolinverbindung.
ATE115129T1 (de) Tetrahydrobenz(c,d>indole als serotonin- agonisten.
ATE34171T1 (de) 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamid .
BR8600715A (pt) Processo para a preparacao de 1,3-tiazol-2-iloxiacetamidas 4,5-dissubstituidas,composicao herbicida,aplicacao e processo para a preparacao de composicoes
DE3668171D1 (de) 1-aryl-5-alkoximinoalkylamino-pyrazole.
DE3174787D1 (de) Aroyl amino acids
FI943386A (fi) CNS-aktiivisuuden omaavia tratsodonin alkyylijohdannaisia
ES2017633B3 (es) Amido derivados.
ES2027654T3 (es) Procedimiento para preparar azafosfolenos.
ES2060964T3 (es) Nuevos compuestos de benzoxazolona y su utilizacion como microbicidas.
DE3577561D1 (de) S-aralkyltrithiophosphonat-insektizide.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment